The United States doubled down on its decades-old support for Taiwan as China flexed its muscles with a second day of ...

Xi said all this shows that China offers a vast stage for business development, vast market prospects, stable policy outlook, and a secure environment, making it a favored choice for foreign ...

AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...

US pharmaceutical giant Pfizer's new research and development (R&D) centre officially opened at BioPark in the Beijing Economic-Technological Development Area (BDA).As the company's third R&D centre ...

AstraZeneca, GSK & partners will source 225GWh of renewable power in China, cutting emissions by 250,000 tonnes – equal to ...

As U.S. President Donald Trump threatens a new round of tariffs as part of an onshoring push, Chinese President Xi Jinping is ...

German investment in China’s auto industry has been one of the few bright spots as foreign investment has slowed to a crawl.

China's President Xi Jinping met with multinational CEOs to urge protection of global industry and supply chains amid U.S. trade tensions. Addressing the concerns over China's economic health, he ...

China's President Xi Jinping met with global CEOs in Beijing on Friday, as the government tries to woo foreign firms whose ...

Billionaire Dalio, head of the world's largest hedge fund, is considered a global authority on investing in China. The bank ...

China's President Xi Jinping met with global CEOs in Beijing on Friday, as the government tries to woo foreign firms whose ...

1. AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing.